Paper38660941
Managing the new wave of weight loss medication in general practice: A qualitative study.
Andreassen P and 3 others. Clin Obes, 2024. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Managing the new wave of weight loss medication in general practice: A qualitative study. Papers, record 38660941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38660941
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Managing the new wave of weight loss medication in general practice: A qualitative study.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| General Practice | Major topic |
| Qualitative Research | Major topic |
| Anti-Obesity Agents | Major topic |
| Humans | |
| Denmark | |
| Female | |
| Male | |
| Weight Loss | |
| Middle Aged | |
| Adult | |
| Obesity | |
| Trust | |
| General Practitioners | |
| Attitude of Health Personnel |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Novo Nordisk Foundation | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 40419330 | Correction to "Managing the New Wave of Weight Loss Medication in General Practice: A Qualitative Study". | https://conductscience.org/library/papers/40419330 |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42859781 | Hope, hype, and high costs: Navigating glucagon-like Peptide-1 based therapy initiation among young adults. | Obes Pillars | 2026 | https://conductscience.org/library/papers/42859781 | PubMed |
| 42630863 | Attitudes Toward Injectable GLP-1 Drugs for Obesity Treatment: A Qualitative Interview Study With Healthcare Professionals. | Obes Sci Pract | 2026 | https://conductscience.org/library/papers/42630863 | PubMed |
| 42608457 | GLP-1 receptor agonists and the emergence of treatment-related stigma: a call for conceptual clarity. | Int J Obes (Lond) | 2026 | https://conductscience.org/library/papers/42608457 | PubMed |
| 42443134 | Treatment Patterns and Experienced Effects of Semaglutide for Weight Management Among Adult Users in Denmark: A Community Pharmacy-Based Cross-Sectional Survey. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/42443134 | PubMed |
| 42181798 | Social Perceptions of Weight Loss With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Black and White Women With Obesity. | Stigma Health | 2026 | https://conductscience.org/library/papers/42181798 | PubMed |
| 42131535 | Drugs, diet, or surgery? How treatment type and willpower shape responsibility for weight loss and judgments of the physician and treatment. | Front Psychol | 2026 | https://conductscience.org/library/papers/42131535 | PubMed |
| 42085357 | Weight Management and Healthcare Utilization among Adults with Overweight and Obesity in Germany: A Representative Survey of General Practitioner Consultations and Digital and Pharmacological Treatment Options. | Obes Facts | 2026 | https://conductscience.org/library/papers/42085357 | PubMed |
| 41838446 | A qualitative study exploring experiences about using semaglutide for weight loss in a rural setting in Denmark - 'she is probably on the meds'. | Scand J Prim Health Care | 2026 | https://conductscience.org/library/papers/41838446 | PubMed |
| 41527217 | Changes in how people living with obesity perceive weight-related discussions with their healthcare professional: Results from the cross-sectional online ACTION-DK 2022 and 2024 studies. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/41527217 | PubMed |
| 41452858 | Beyond the prescription: Global observations on the social implications of GLP-1 receptor agonists for weight loss. | PLOS Glob Public Health | 2025 | https://conductscience.org/library/papers/41452858 | PubMed |
| 41299124 | Primary Care Providers Perspectives of GLP-1 Receptor Agonists to Manage Recurrent Weight Gain after Metabolic Bariatric Surgery - a Qualitative Study. | Obes Surg | 2026 | https://conductscience.org/library/papers/41299124 | PubMed |
| 40903862 | Treat to target in weight management with semaglutide: Real-world evidence from an eHealth clinic. | Diabetes Obes Metab | 2025 | https://conductscience.org/library/papers/40903862 | PubMed |
| 40628416 | GPs' perspectives on GLP-1RAs for obesity management: a qualitative study in England. | Br J Gen Pract | 2025 | https://conductscience.org/library/papers/40628416 | PubMed |
| 40521912 | 'This Is My Decision': A Qualitative Study of Individuals' Perspectives on Use of Semaglutide for Weight Loss. | Basic Clin Pharmacol Toxicol | 2025 | https://conductscience.org/library/papers/40521912 | PubMed |
| 40306953 | GLP-1 Receptor Agonists for Treatment of Pediatric Obesity: Behavioral Health Considerations. | Child Obes | 2025 | https://conductscience.org/library/papers/40306953 | PubMed |
| 40227008 | What Are the Experiences, Views and Perceptions of Patients, Carers and Clinicians of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs)? A Scoping Review. | Health Expect | 2025 | https://conductscience.org/library/papers/40227008 | PubMed |
| 39907856 | The Impact of Novel Medications for Obesity on Weight Stigma and Societal Attitudes: A Narrative Review. | Curr Obes Rep | 2025 | https://conductscience.org/library/papers/39907856 | PubMed |
| 39905646 | Survey among adult users of semaglutide for weight loss in Denmark: User characteristics, treatment expectations and experienced effects. | Diabetes Obes Metab | 2025 | https://conductscience.org/library/papers/39905646 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38660941
GET https://conductscience.org/api/papers/v1/38660941/authors